Multicenter Clinical Performance Evaluation of the NeuMoDx CT/NG Assay 2.0

20240 citationsJournal Articlehybrid Open Access

Authors

Barbara Van Der Pol · University of Alabama at Birmingham

Ann Avery · MetroHealth

Steven N. Taylor · Louisiana State University Health Sciences Center New Orleans

J. Philip Miller · Henry Ford Health System

Christopher L. Emery · Indiana University Health

Alistair English · Qiagen (United Kingdom)

G Lazenby ·

Abstract

The NeuMoDx CT/NG Assay 2.0 demonstrated performance similar to currently US Food and Drug Administration-cleared assays, with the added choice of a moderate- (96-sample) or a high-throughput (288-sample) platform. The system therefore offers solutions to laboratories running lower volumes of testing that may obviate the need for outsourcing to larger reference laboratories.

Topics & Keywords

Reproductive tract infections research Urinary Tract Infections Management Cervical Cancer and HPV Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Sexually Transmitted Diseases

Volume 52, Issue 7, pp. 422-427

DOI: 10.1097/olq.0000000000002075

Field-Weighted Citation Impact: 0.00